The document discusses Roche's innovation process, including strategies around patenting, fundraising, and collaborations with large pharmaceutical companies and patient organizations. It also describes Roche's Startup Creasphere program, which selects startups every 6 months for an accelerator program involving coaching, mentoring, and co-working on pilots to foster collaboration and one Roche approach. The goal is ongoing collaborations with at least 50% of startups.

1. Il processo di innovazione in atto: dalle strategie di
brevettazione al fundraising fino alle collaborazioni con le big
pharma e le organizzazioni di pazienti
Riccardo Triunfo, International Product Manager, Roche Diagnostics,
Parco Scientifico e Tecnologico della Sardegna, 3 Aprile 2019

2. 2 © 2019 Roche
Aprire il sito
www.menti.com
Ed inserire il codice
12 39 80
2 © 2019 Roche

3. 3 © 2019 Roche
Technology is changing our world, affecting
everything we do in our daily lives.
3 © 2019 Roche

4. Roche is a global pioneer in personalised healthcare
Innovation: it’s in our DNA
CHF 11.0 billion R&D investment
30 R&D sites worldwide *
CHF 56.8 billion sales
26 manufacturing sites worldwide
3
*Pharmaceuticals and Diagnostics ** Strategy & Global Innovation 1000, Winter 2017
94,442employees worldwide
#1 R&D investor in healthcare**
Among top 10 R&D investors across industries

5. We make a meaningful difference in healthcare
Healthcare expertise that is unique in breadth and depth
4
Early detection Prevention Diagnosis Therapy Therapy monitoring
Our broad footprint in
healthcare and scientific
expertise allow us to
build and analyse
meaningful data at scale
to transform healthcare
for patients and society
Leader in PharmaLeader in Diagnostics

6. 7
The world needs better ways to prevent, diagnose and treat
diseases
2/3 of diseases
are either still not treated
adequately or not treated at all
only 4%
of patients are in clinical trials;
we are missing valuable
insights and data from 96%
1/2 the world
lacks access to essential
health services
71%
of all deaths globally are
caused by non-communicable
diseases (NCDs) and therefore
the medical need is urgent

7. 7 © 2019 Roche
Over 20 billion tests conducted in
Roche Diagnostics products.
7 © 2019 Roche

8. 8 © 2019 Roche
Health systems are facing pressure
to transform from volume to value
Aging population
Declining reimbursement
Rising quality standards & complexity
Short supply of skilled workforce
Treatment of chronic disease
Healthcare sustainability,
a growing global concern

9. 9 © 2019 Roche
The data challenge
Navigating the digitalization of healthcare
Manual
processes
in a
digital world Lack of
transparency
&
connectivity
Siloed
systems
&
healthcare
professionals
Increasing
volumes
of
disparate data
Healthcare
professionals need
data-driven insights
to make more
informed decisions.
Complexity
of
identifying
relevant data

10. 10 © 2019 Roche
Roche Digital Diagnostics enables personalized healthcare at scale
Closing clinical care gaps throughout the patient journey
Diagnosis
Solutions
Treatment
Medicines
Imaging
Data
Digital
Pathology
Genomics
Data
Claims
Data
Clinical
Trial
Data
EHR
Data
Device/App
Data
Lab
Data

11. How we do innovation. Startup Creasphere
Why we created it
Access to
(disruptive)
innovation
Real and early
engagement
Talent
attraction
Foster
One Roche
approach
Agile and
iterative process
Change of
mindset

12. Startup Creasphere Program
Cyclic co-working phases provide fast results and mutual benefits
Selection - every 6 months Accelerator Program Collaboration
ActionsObjectives
• Based on Roche focus areas
• Identify globally best startups
• Coaching and mentoring
• Learning from each other from
co-working on pilot
• Joint development
• Co-Marketing
• Ongoing collaborations
with at least 50% of
startups
Operator:

13. 13
Partnering - Areas of interest
www.roche.com/partnering

14. Everyone is talking about
bringing technology
to healthcare.
We´re bringing
healthcare thinking
to technology to
impact patients´lives.

15. Doing now what patients need next